Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Will Not Acquire Berna

This article was originally published in The Pink Sheet Daily

Executive Summary

Novartis will not extend an acquisition offer to Swiss vaccines company Berna Biotech, the firms announced Jan. 10

You may also be interested in...



Crucell Gains Contract Manufacturing Company With SBL Acquisition

Acquisition, valued at $50.5 mil., is expected to complete on Nov. 23.

Crucell Gains Contract Manufacturing Company With SBL Acquisition

Acquisition, valued at $50.5 mil., is expected to complete on Nov. 23.

Novartis Considers Joining Swiss Vaccines Firm Berna With Chiron

The firm would have to outbid a roughly $450 mil. bid from Dutch biotech company Crucell.

Topics

UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel